Tamiya, Motohiro
Tamiya, Akihiro
Okamoto, Norio
Taniguchi, Yoshihiko
Nishino, Kazumi
Atagi, Shinji
Hirashima, Tomonori
Imamura, Fumio
Kumagai, Toru
Suzuki, Hidekazu
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 25 January 2021
Accepted: 14 April 2021
First Online: 5 May 2021
Competing interests
: Motohiro Tamiya has a research grant from Boehringer Ingelheim and receives lecture fee from Boehringer Ingelheim, Chugai Pharmaceutical, and AstraZeneca. Akihiro Tamiya has a research grant from AstraZeneca and receives lecture fee from Boehringer Ingelheim, Chugai Pharmaceutical, and AstraZeneca. Yoshihiko Taniguchi receives lecture fee from AstraZeneca. Kazuo Nishino has a research grant from Boehringer Ingelheim and receives lecture fee from Boehringer Ingelheim, Chugai Pharmaceutical, and AstraZeneca. Fumio Imamura has a research grant from AstraZeneca. Other authors have no conflicts of interest to declare under consideration for publication.